Peer Review Process & Policy

The International Journal of Advanced Medical and Clinical Therapeutics (IJAMCT) upholds a meticulous double-blind peer-review process, designed to guarantee the impartiality and integrity of manuscript evaluations. In this system, both the reviewers and authors remain anonymous throughout the review process. This anonymity is crucial for minimizing biases and ensuring that the assessment of the manuscript is based solely on its scientific and academic merits.

Process Overview:

• Initial Submission: Upon submission, each manuscript is first screened by the editorial team to ensure it meets the journal's scope and basic requirements. Manuscripts that pass this initial screening are then forwarded to expert reviewers.
• Double-Blind Review: The core of our review process is double-blind, meaning that neither the authors nor the reviewers are aware of each other’s identities. This anonymity helps prevent any potential bias and ensures that the manuscript's evaluation focuses solely on the content and quality of the research presented.
• Reviewer Selection: The journal selects reviewers based on their expertise in the subject matter of the manuscript. Reviewers are chosen for their knowledge, experience, and ability to provide objective, constructive feedback.
• Review Rounds: The peer-review process often involves multiple rounds. Reviewers assess the manuscript for its scientific validity, originality, methodology, and overall contribution to the field. They provide detailed feedback and suggestions for improvement. Authors are then required to revise their manuscript accordingly and resubmit it for further evaluation.
• Feedback and Revisions: Reviewers’ comments are communicated to the authors, who are expected to address the feedback and make necessary revisions. This iterative process continues until the manuscript meets the required standards for publication.
• Decision-Making: After the final round of review, the editorial team makes a publication decision based on the reviewers' recommendations. Manuscripts may be accepted, rejected, or returned to the authors for further revisions.

Timeline:

• Submission to First Decision: The typical timeline for the peer-review process is between 4 to 6 weeks from the initial submission to the first decision. This timeframe may vary depending on the complexity of the manuscript and the availability of suitable reviewers.
• Commitment to Fairness and Transparency: The International Journal of Advanced Medical and Clinical Therapeutics is dedicated to maintaining a transparent and fair review process. We strive to ensure that every manuscript is reviewed with the highest level of academic rigor and integrity. Our goal is to support the advancement of medical and clinical knowledge through a thorough and unbiased evaluation of all submitted research.